These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2349682)

  • 61. Cyclosporine and liver transplantation.
    Calne RY
    Mt Sinai J Med; 1987 Sep; 54(6):465-6. PubMed ID: 3317017
    [No Abstract]   [Full Text] [Related]  

  • 62. Cyclosporine and immunosuppressive regimens in renal transplantation.
    Canafax DM; Sutherland DE; Matas AJ; Payne WD; Dunn DL; Najarian JS
    N Engl J Med; 1988 Nov; 319(19):1287-8. PubMed ID: 3054547
    [No Abstract]   [Full Text] [Related]  

  • 63. Transdermal application of cyclosporine prolongs skin allograft survival.
    Black KS; Hewitt CW; Chau CL; Pizzo L
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):660-2. PubMed ID: 3284115
    [No Abstract]   [Full Text] [Related]  

  • 64. Suspected drug interaction between cyclosporine and clarithromycin.
    Gersema LM; Porter CB; Russell EH
    J Heart Lung Transplant; 1994; 13(2):343-5. PubMed ID: 8031821
    [No Abstract]   [Full Text] [Related]  

  • 65. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
    Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
    [No Abstract]   [Full Text] [Related]  

  • 66. Pharmacokinetics of cyclosporine in solid organ transplantation.
    Keown PA; Stiller CR; Stawecki M; Freeman D
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):160-4. PubMed ID: 3538567
    [No Abstract]   [Full Text] [Related]  

  • 67. [Cyclosporin in transplantation management--especially after kidney transplantation].
    Quellhorst E
    Internist (Berl); 1996 Jan; 37(1):88-90. PubMed ID: 8837834
    [No Abstract]   [Full Text] [Related]  

  • 68. Minimal low dosage of cyclosporine therapy in renal transplantation by careful monitoring of high-performance liquid chromatography whole blood trough levels.
    Uchida K; Yamada N; Orihara A; Tominaga Y; Tanaka Y; Hayashi S; Kondo T; Morozumi K; Satake M; Taira N
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):394-401. PubMed ID: 3284083
    [No Abstract]   [Full Text] [Related]  

  • 69. Cyclosporine dose adjustment in patients with normal serum creatinine and trough levels: a challenge for successful long-term treatment.
    Cantarovich F; Cantarovich D; Touraine JL; Tizado J; Castro LZ; Correa C; Herman AP; Traeger J
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):402-6. PubMed ID: 3284084
    [No Abstract]   [Full Text] [Related]  

  • 70. Clinical development of cyclosporine.
    Beveridge T
    Transplant Proc; 1992 Aug; 24(4 Suppl 2):64-6. PubMed ID: 1496691
    [No Abstract]   [Full Text] [Related]  

  • 71. Cyclosporine measurement by FPIA, PC-RIA, and HPLC following liver transplantation.
    Burckart GJ; Jain A; Diven W; Venkataramanan R; Starzl TE
    Transplant Proc; 1990 Jun; 22(3):1319-22. PubMed ID: 2190393
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Conversion from cyclosporine to azathioprine after renal transplantation: long-term effects on renal function, rejection, and allograft survival.
    Maddux MS; Veremis SA; Bauma WD; Pollak R; Mozes MF
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):152-4. PubMed ID: 3291231
    [No Abstract]   [Full Text] [Related]  

  • 73. Intravenous administration of cyclosporine for immunosuppression in heart transplant patients.
    Macris MP; Frazier OH; Van Buren CT; Lammermeier DE; Sweeney MS; Kahan BD
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2487. PubMed ID: 2650311
    [No Abstract]   [Full Text] [Related]  

  • 74. Is cyclosporine administration in twice daily dose advantageous?
    Savoldi S; Sandrini S; Scolari F; Brunori G; Prati E; Camerini C; Scaini P; Cristinelli L; Maiorca R
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1720-2. PubMed ID: 3274414
    [No Abstract]   [Full Text] [Related]  

  • 75. Cyclosporine-associated nephrotoxicity is not intractable.
    Loertscher R
    Transplant Proc; 1987 Aug; 19(4):3486-9. PubMed ID: 3303520
    [No Abstract]   [Full Text] [Related]  

  • 76. Comparison of cyclosporine A dosage and metabolism in liver and heart transplant recipients.
    Hamilton G; Mühlbacher F; Roth E; Wolf I; Piza F; Havel M; Laczkovics A; Schindler J; Wolosczuk W
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1706-8. PubMed ID: 3547878
    [No Abstract]   [Full Text] [Related]  

  • 77. Optimization of the blood sample filter paper technique for cyclosporine determination.
    Manrique RV; Lin HT
    Transplant Proc; 1990 Jun; 22(3):1231-3. PubMed ID: 2349685
    [No Abstract]   [Full Text] [Related]  

  • 78. Effects of steroids in combination with other pharmacologic immunosuppressive agents.
    Salaman JR
    J Heart Transplant; 1986; 5(4):304-6. PubMed ID: 3305822
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacokinetic interactions between cyclosporine and other drugs.
    Yee GC
    Transplant Proc; 1990 Jun; 22(3):1203-7. PubMed ID: 2190382
    [No Abstract]   [Full Text] [Related]  

  • 80. Influence of early cyclosporine dosage and plasma and whole blood levels on acute rejections in cadaveric renal allograft recipients.
    Lindholm A; Lundgren G; Fehrman I; Weibull H; Brynger H; Frödin L; Flatmark A
    Transplant Proc; 1988 Jun; 20(3):444-6. PubMed ID: 3289181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.